In-Stent Restenosis and Stent Thrombosis: An Elusive Target
- PMID: 39131648
- PMCID: PMC11307575
- DOI: 10.1016/j.jscai.2023.100972
In-Stent Restenosis and Stent Thrombosis: An Elusive Target
Keywords: in-stent restenosis; percutaneous coronary intervention; stent thrombosis.
Figures
Comment on
- doi: 10.1016/j.jscai.2023.100971
References
-
- Sigwart U., Puel J., Mirkovitch V., Joffre F., Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med. 1987;316(12):701–706. - PubMed
-
- Serruys P.W., de Jaegere P., Kiemeneij F., et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med. 1994;331(8):489–495. - PubMed
-
- Tada T., Byrne R.A., Simunovic I., et al. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients. J Am Coll Cardiol Intv. 2013;6(12):1267–1274. - PubMed
-
- Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349(14):1315–1323. - PubMed
-
- Stettler C., Wandel S., Allemann S., et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet. 2007;370(9591):937–948. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
